CliffBio
small molecule

GLYCEROL PHENYLBUTYRATE

GLYCEROL PHENYLBUTYRATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameGLYCEROL PHENYLBUTYRATE
Active ingredientGLYCEROL PHENYLBUTYRATE
Strength1.1GM/ML
Dosage formLIQUID
RouteORAL
ModalitySmall molecule
FDA approvalApril 2026
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.